0001637514-15-000001.txt : 20150326 0001637514-15-000001.hdr.sgml : 20150326 20150326094242 ACCESSION NUMBER: 0001637514-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150326 DATE AS OF CHANGE: 20150326 EFFECTIVENESS DATE: 20150326 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cytocentrics, Inc. CENTRAL INDEX KEY: 0001637514 IRS NUMBER: 472789100 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-236673 FILM NUMBER: 15726447 BUSINESS ADDRESS: STREET 1: 18618 TUSCANY STONE, SUITE 120 CITY: SAN ANTONIO STATE: TX ZIP: 78258 BUSINESS PHONE: 941-914-1200 MAIL ADDRESS: STREET 1: 18618 TUSCANY STONE, SUITE 120 CITY: SAN ANTONIO STATE: TX ZIP: 78258 D 1 primary_doc.xml X0707 D LIVE 0001637514 Cytocentrics, Inc. 18618 TUSCANY STONE, SUITE 120 SAN ANTONIO TX TEXAS 78258 941-914-1200 DELAWARE None None Corporation true 2014 James R. Garvin 18618 Tuscany Stone Suite 120 San Antonio TX TEXAS 78258 Executive Officer Director Chief Executive Officer, President, Secretary and Treasurer Biotechnology Decline to Disclose 06b false 2015-03-06 false true true 0 Indefinite 0 Indefinite The shares were issued in connection with the acquisition of the equity interests in another entity. The value of the securities issued in the offering is not known to the Issuer. false 2 0 0 0 false Cytocentrics, Inc. James R. Garvin James R. Garvin CEO 2015-03-26